AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
December 2010
Volume: 2
Issue: 7
Specialty Pharmacy
Volume: 2
Issue: 6
October 2010
Volume: 2
Issue: 5
August 2010
Volume: 2
Issue: 4
June 2010
Volume: 2
Issue: 3
April 2010
Volume: 2
Issue: 2
February 2010
Volume: 2
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
2
Frontline Immunotherapy Options in NSCLC: Are Checkpoint Inhibitors Interchangeable?
3
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
4
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
5